The muscle nicotinic acetylcholine receptor (nAChR) is a large, allosteric, ligand-gated ion channel with the subunit composition α 2 βγδThough much is now known about the structure of the binding site, relatively little is understood about how the binding event is communicated to the channel gate, causing the pore to open. Here we identify a key hydrogen bond near the binding site that is involved in the gating pathway. Using mutant cycle analysis with the novel unnatural residue α-hydroxyserine (Sah), we find that the backbone N-H of αS191 in loop C makes a hydrogen bond to an anionic side chain of the complementary subunit upon agonist binding. However, the anionic partner is not the glutamate predicted by the crystal structures of the homologous acetylcholine binding protein (AChBP). Instead, the hydrogen bonding partner is the extensively researched aspartate γD174/δD180-which had originally been identified as a key binding residue for cationic agonists.
II-2 arranged symmetrically around a central ion-conducting pore with the stoichiometry α 2 βγδ. The agonist binding sites are located at the interfaces between the αγ and αδ subunits. The binding of two agonist molecules induces a conformational change that leads to the opening of the ion channel.
It is now widely appreciated that a tryptophan residue (αW149) plays a key role in neurotransmitter binding by forming a cation-π interaction with the quaternary ammonium group of acetylcholine{Zhong, 1998 #15}, a result supported by structural data. However, many other important residues in the immediate vicinity of the binding site have been identified. In a classic experiment on the Torpedo nAChR (a close homologue of the muscle subtype), Czajkowski In the present work we evaluate several anionic residues in loop F and potential interactions with loop C. Using a combination of natural and unnatural mutagenesis, we find that, indeed, the backbone N-H of αS191 does make a hydrogen bond to a loop F residue. 
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However, the partner is not the glutamate seen in the AChBP crystal structure. Instead, the aspartate (γD174/δD180) originally identified by Czajkowski and Karlin is the hydrogen bonding partner.
Results

A Backbone Mutation at αS191 Has a Large Impact on Receptor Function
In the process of probing the backbone flexibility surrounding the nAChR binding box, we mutated αS191 to α-hydroxyserine (Sah). This produces an ester backbone linkage at this position, while preserving the side chain. Along with increasing backbone flexibility, this mutation removes the hydrogen bond-donating N-H group and replaces it with a non-hydrogen bond-donating O (Figure 2 Figure 2 .2b). We also made alanine and α-hydroxyalanine (Aah) mutations at this site. The side chain mutation alone had minimal impact on receptor function, producing no shift in EC 50 . However, receptor function of the αS191Aah mutant was dramatically impaired relative to αS191Ala, confirming that the backbone-and not the side chain-at αS191 is important for receptor function. 
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Mutant
Evaluating anionic residues on loop F
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To evaluate the potential hydrogen bond from αS191 to γE176/δE182, we made several mutations at this glutamate. Surprisingly, all mutations have minimal impact, suggesting no critical role for this residue. Another nearby loop F glutamate residue, γE169/δE175, was also evaluated. Again, no significant impact is seen.
In sharp contrast, even the subtlest mutations at γD174/δD180 produce large effects on receptor function, a result that others have also seen{Czajkowski, 1991 #1; Czajkowski, 1995 #2;
Martin, 1996 #5; Martin, 1997 #4}. We first studied asparagine, glutamate and glutamine mutations at this site. The γD174E/δD180E mutant exhibits a modest ~3-fold decrease in EC 50 .
However, the γD174N/δD180N and γD174Q/δD180Q mutants produce substantial (>100-fold) changes to the EC 50 ( Figure 2 .2b and Table 2 .1).
Fundamentally, the results of these conventional mutations strongly implicate the side chain of γD174/δD180 in an electrostatic interaction, such as an ion pair or hydrogen bond.
However, changing the side chain functionality from a carboxylate to an amide not only neutralizes the charge on the side chain, it also desymmetrizes it and introduces a potential hydrogen bond donor. To better understand the role of γD174/δD180, we incorporated two unnatural amino acids.
Nitrohomoalanine (Nha) is an analogue of glutamate that contains a nitro (NO 2 ) group, which is isosteric and isoelectronic to a carboxylate, but it has no charge and is a much weaker hydrogen bond acceptor (Figure 2 .2a). * Incorporation of Nha at γD174/δD180 yields a slightly less dramatic effect than the γD174N/δD180N and γD174Q/δD180Q mutants, producing a 24-* Although nitroalanine, the analogue of aspartate, would be ideal, it is not chemically compatible with the nonsense suppression methodology. Given that the mutation γD174E/δD180E produces a very modest EC 50 shift and that γD174N/δD180N and γD174Q/δD180Q show similar effects on receptor function, the comparison of Nha to Glu can be considered meaningful.
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fold shift in EC 50 relative to γD174E/δD180E (Figure 2 .2b). Thus, charge neutralization at this site significantly affects receptor function but cannot fully account for the EC 50 shift seen in the γD174N/δD180N and γD174Q/δD180Q mutants.
The second unnatural amino acid analogue incorporated at γD174/δD180 was 2-amino- Mutations at individual binding sites (αβγD174Nδ and αβγδD180N) showed substantial (~50-fold) and approximately equivalent increases in whole cell EC 50 .
4-ketopentanoic acid (Akp). Akp is isoelectronic to
Mutant cycle analysis reveals a strong interaction between the αS191 backbone and the side chain of γD174/δD180
Mutant cycle analysis was performed between several of the side chain mutations at γD174/δD180 and the αS191Sah mutation (Figure 2 .3, 2.4). Briefly, mutant cycle analysis is used to determine the pairwise interaction energy between two residues in a protein using the equation given in Figure 2 .3. If the two residues do not interact, the change in free energy for the simultaneous mutation of both residues should simply be the sum of the free energy of each of the individual mutations. However, for residues that interact, the change in free energy for the double mutation will be non-additive. EC 50 -based mutant cycle analysis has been used to 
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Lengthening the side chain (γD174E/δD180E) has no impact on the interaction between these two residues (ΔΔG = 0.12 kcal/mol). In contrast, mutant cycle analysis between γD174N/δD180N and αS191Sah indicates a large energetic coupling (ΔΔG = 2.1 kcal/mol). A smaller but still quite significant effect is seen for the mutant cycle analysis between γD174Nha/δD180Nha and αS191Sah (ΔΔG = 1.4 kcal/mol). Mutant cycle analyses of γD174N/δD180N with αS191A and αS191Aah further support the conclusion that the interaction between these residues involves the backbone of αS191 and not the side chain (αS191Ala: ΔΔG = 0.25; αS191Aah: ΔΔG = 2.3 kcal/mol). Not surprisingly, comparable mutant cycle analyses of the two glutamates of loop F, γE176/δE182 and γE169/δE175, with αS191Sah showed no significant coupling.
Discussion
The While γD174/δD180 is remote to the agonist binding site in AChBP, another loop F anionic residue, γE176/δE182, appears to make a hydrogen bond to a backbone N-H that is integral to the aromatic box of the agonist binding site when the agonist carbamylcholine is bound. Using nonsense suppression methodology, we have been able to specifically remove the backbone N-H in question by replacing αS191 with its α-hydroxy analogue. Consistent with the AChBP images, this subtle structural change has a large effect on receptor function, suggesting that a hydrogen bond to this moiety is important. However, consistent with prior mutational analyses{Czajkowski, 1995 #2; Czajkowski, 1993 #3; Martin, 1996 #5}, we find that γE176/δE182
does not play a large role in receptor function. This suggests that AChBP does not provide an accurate model of the muscle nAChR in this region. Given that the sequence alignment in this region shows a number of insertions in nAChR relative to AChBP-combined with the fact that the F loop is believed to be involved in gating the nAChR (AChBP does not gate)-it is not surprising that AChBP would be an unreliable model here.
Our results indicate that the hydrogen-bonding partner for the backbone N-H of αS191 in the nAChR is instead the side chain of γD174/δD180. Based on the available structural and functional data, we suggest that this hydrogen bond exists in the open state only{Akk, 1999 #14;
Martin, 1996 #5; Martin, 1997 #4}. As others have seen, a number of mutations of this side chain profoundly affect receptor function. Here we employ several relatively subtle mutations.
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The fact that substantial functional consequences are seen suggests a precise structural role for this side chain in at least one state crucial for activating the channel. Furthermore, all mutations at γD174/δD180 that significantly impact function also show strong coupling to the αS191Sah backbone mutation via mutant cycle analysis. The nature of the coupling is as one would expect from the hydrogen bonding model: mutation at either site has a strong effect; however, once the αS191Sah mutation is introduced-removing any possible hydrogen bonding interactionmutations at γD174/δD180 have a much smaller impact. Interestingly, no specific role for the side chain of αS191 is found, as the αS191A mutant gives essentially wild type behavior. † However, when the alanine side chain is combined with the α-hydroxy backbone mutation, the same coupling to γD174/δD180 is observed.
We propose that the movement of loop This model is also consistent with the γD174/δD180 mutants described here.
Lengthening the sidechain of this key F loop residue (γD174E/δD180E) effects a modest improvement in receptor function, either because the longer side chain can more easily reach its αS191 hydrogen bonding partner, or because it fits more poorly in the hydrophobic pocket, destabilizing the closed state. Any mutation that eliminates side chain charge has a significant § The possibility of a salt bridge forming here can be eliminated, given that there are no basic residues in the C loop or in its vicinity.
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impact on function, which is expected, given that these mutant side chains are poorer hydrogen bond acceptors and that they experience a much lower energetic solvation benefit upon moving from the hydrophobic pocket into an aqueous environment.
In conclusion, mutant cycle analysis involving a novel backbone mutant has identified an important interaction between an F loop residue that has long been thought to contribute to receptor function and the peptide backbone of loop C. The hydrogen bond between the side chain of γD174/δD180 and the backbone of αS191 likely forms upon agonist binding and is part of the agonist-induced conformational changes that lead to channel opening. Along with contributing new insights into the gating pathway of the nAChR, our results reconcile a longstanding discrepancy between early biochemical studies of the receptor and structural models from the AChBP systems.
Materials and Methods
Preparation of Unnatural Amino and Hydroxy Acids
All chemical reactions were performed under argon using solvent-column dry solvents{Pangborn, 1996 #22}. Flasks and vials were oven dried at 122C and cooled in a 
Synthesis of 2,3-dihydroxypropionate (-hydroxyserine, Sah)-tRNA
Glycerate, calcium salt dihydrate (286 mg, 2.0 mmol) was measured into a 100 mL round-bottomed flask. Methanol (40 mL) and toluene (10 mL) were added, followed by conc. 
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The transesterification and deprotection of 2,3-di-tert-butyldimethylsilylglycerate cyanomethyl ester were performed according to published protocols to yield Sah-tRNA{Nowak, 1998 #35}.
Side chain and backbone mutagenesis
Conventional mutagenesis and unnatural mutagenesis, with the site of interest mutated to either an amber stop codon or a four base frameshift codon (at αS191), were achieved by a standard Stratagene QuikChange protocol. Sequencing through both strands confirmed the presence of the desired mutation. Mouse muscle embryonic nAChR in the pAMV vector was used. All the mutations were made in the presence of a background transmembrane mutation 
Electrophysiology
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The function of mutant receptors was evaluated using two-electrode voltage clamp.
Stage V-VI oocytes of Xenopus laevis were employed. Oocyte recordings were made 12-48 h postinjection in two-electrode voltage clamp mode using the OpusXpress 6000A instrument (Axon Instruments, Union City, CA). Oocytes were superfused with a Ca
2+
-free ND96 solution at flow rates of 1 mL/min before application, 4 mL/min during drug application, and 3 mL/min during wash. Holding potential was -60 mV. Data were sampled at 125 Hz and filtered at 50 Hz.
Drug applications were 15 s in duration. Acetylcholine chloride was purchased from Sigma/Aldrich/RBI. Solutions ranging from 0.01 to 5000 μM were prepared in Ca 
